Suppr超能文献

RIIβ连接子和N端环核苷酸结合结构域在决定IIβ型蛋白激酶A独特结构中的作用:小角X射线和中子散射研究

The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.

作者信息

Blumenthal Donald K, Copps Jeffrey, Smith-Nguyen Eric V, Zhang Ping, Heller William T, Taylor Susan S

机构信息

From the Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112,

the Howard Hughes Medical Institute and Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0654.

出版信息

J Biol Chem. 2014 Oct 10;289(41):28505-12. doi: 10.1074/jbc.M114.584177. Epub 2014 Aug 11.

Abstract

Protein kinase A (PKA) is ubiquitously expressed and is responsible for regulating many important cellular functions in response to changes in intracellular cAMP concentrations. The PKA holoenzyme is a tetramer (R2:C2), with a regulatory subunit homodimer (R2) that binds and inhibits two catalytic (C) subunits; binding of cAMP to the regulatory subunit homodimer causes activation of the catalytic subunits. Four different R subunit isoforms exist in mammalian cells, and these confer different structural features, subcellular localization, and biochemical properties upon the PKA holoenzymes they form. The holoenzyme containing RIIβ is structurally unique in that the type IIβ holoenzyme is much more compact than the free RIIβ homodimer. We have used small angle x-ray scattering and small angle neutron scattering to study the solution structure and subunit organization of a holoenzyme containing an RIIβ C-terminal deletion mutant (RIIβ(1-280)), which is missing the C-terminal cAMP-binding domain to better understand the structural organization of the type IIβ holoenzyme and the RIIβ domains that contribute to stabilizing the holoenzyme conformation. Our results demonstrate that compaction of the type IIβ holoenzyme does not require the C-terminal cAMP-binding domain but rather involves large structural rearrangements within the linker and N-terminal cyclic nucleotide-binding domain of the RIIβ homodimer. The structural rearrangements are significantly greater than seen previously with RIIα and are likely to be important in mediating short range and long range interdomain and intersubunit interactions that uniquely regulate the activity of the type IIβ isoform of PKA.

摘要

蛋白激酶A(PKA)广泛表达,负责响应细胞内cAMP浓度变化来调节许多重要的细胞功能。PKA全酶是一种四聚体(R2:C2),由一个调节亚基同二聚体(R2)结合并抑制两个催化(C)亚基组成;cAMP与调节亚基同二聚体的结合会激活催化亚基。哺乳动物细胞中存在四种不同的R亚基异构体,它们赋予所形成的PKA全酶不同的结构特征、亚细胞定位和生化特性。含有RIIβ的全酶在结构上是独特的,因为IIβ型全酶比游离的RIIβ同二聚体更加紧凑。我们利用小角X射线散射和小角中子散射来研究含有RIIβ C末端缺失突变体(RIIβ(1 - 280))的全酶的溶液结构和亚基组织,该突变体缺失C末端cAMP结合结构域,以便更好地理解IIβ型全酶的结构组织以及有助于稳定全酶构象起作用的RIIβ结构域。我们的结果表明,IIβ型全酶的紧凑化不需要C末端cAMP结合结构域,而是涉及RIIβ同二聚体的连接区和N末端环核苷酸结合结构域内的大规模结构重排。这些结构重排比之前在RIIα中观察到的要大得多,并且可能在介导独特调节PKA IIβ异构体活性的短程和长程结构域间及亚基间相互作用中起重要作用。

相似文献

2
Structure and allostery of the PKA RIIβ tetrameric holoenzyme.
Science. 2012 Feb 10;335(6069):712-6. doi: 10.1126/science.1213979.
5
Novel isoform-specific interfaces revealed by PKA RIIbeta holoenzyme structures.
J Mol Biol. 2009 Nov 13;393(5):1070-82. doi: 10.1016/j.jmb.2009.09.014. Epub 2009 Sep 11.
6
Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
Biochemistry. 2004 May 18;43(19):5629-36. doi: 10.1021/bi0499157.
8
Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16347-16356. doi: 10.1073/pnas.1906036116. Epub 2019 Jul 30.
9
Realizing the allosteric potential of the tetrameric protein kinase A RIα holoenzyme.
Structure. 2011 Feb 9;19(2):265-76. doi: 10.1016/j.str.2010.12.005.

引用本文的文献

1
Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).
J Biol Chem. 2015 Nov 27;290(48):28631-41. doi: 10.1074/jbc.M115.685305. Epub 2015 Sep 14.

本文引用的文献

1
New developments in the program package for small-angle scattering data analysis.
J Appl Crystallogr. 2012 Mar 15;45(Pt 2):342-350. doi: 10.1107/S0021889812007662. eCollection 2012 Apr 1.
2
Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
Science. 2014 May 23;344(6186):917-20. doi: 10.1126/science.1252328.
3
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
Nat Genet. 2014 Jun;46(6):613-7. doi: 10.1038/ng.2956. Epub 2014 Apr 20.
4
Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Science. 2014 May 23;344(6186):913-7. doi: 10.1126/science.1249480. Epub 2014 Apr 3.
5
PKA signaling drives mammary tumorigenesis through Src.
Oncogene. 2015 Feb 26;34(9):1160-73. doi: 10.1038/onc.2014.41. Epub 2014 Mar 24.
6
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
N Engl J Med. 2014 Mar 13;370(11):1019-28. doi: 10.1056/NEJMoa1310359. Epub 2014 Feb 26.
7
Signaling through dynamic linkers as revealed by PKA.
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14231-6. doi: 10.1073/pnas.1312644110. Epub 2013 Aug 14.
8
Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease.
Mol Cell Biol. 2013 Mar;33(5):1073-84. doi: 10.1128/MCB.01434-12. Epub 2012 Dec 28.
9
Creating order from chaos: cellular regulation by kinase anchoring.
Annu Rev Pharmacol Toxicol. 2013;53:187-210. doi: 10.1146/annurev-pharmtox-011112-140204. Epub 2012 Oct 8.
10
Assembly of allosteric macromolecular switches: lessons from PKA.
Nat Rev Mol Cell Biol. 2012 Oct;13(10):646-58. doi: 10.1038/nrm3432. Epub 2012 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验